Physician profile
Nirali H Patel
NPI 1710105366
$1,984.13
in general payments reported to CMS, 2019-2025
17 companies · $636 in 2025
The $636 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $296 · 2023: $451 · 2024: $601 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $413.74 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $405.68 | 2022-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $147.67 | 2025 | Jornay Pm |
| Neos Therapeutics, LP | $146.29 | 2022-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Supernus Pharmaceuticals, INC. | $142.19 | 2024-2025 | Qelbree |
| Glaxosmithkline, LLC. | $132.61 | 2022-2025 | Bexsero |
| Pfizer INC. | $123.78 | 2022-2025 | |
| Cranial Technologies, INC | $82.01 | 2022-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $75.17 | 2022-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sobi, INC | $72.26 | 2022-2024 | |
| Tris Pharma INC | $53.91 | 2022-2025 | Dyanavel Xr |
| Cognoa, INC. | $51.45 | 2022 | |
| Sanofi Pasteur INC. | $42.78 | 2024 | |
| Vertical Pharmaceuticals, LLC | $33.28 | 2024 | Relexxii |
| Janssen Biotech, INC. | $33.14 | 2023 | Tremfya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.42 | 2022 | |
| Seqirus USA INC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirali Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.